Delineation of lung cancer with FDG PET/CT during radiation therapy

about

Delineation of lung cancer with FDG PET/CT during radiation therapy

Item

http://www.wikidata.org/entity/Q59127541

description

im November 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Delineation of lung cancer with FDG PET/CT during radiation therapy

@en

Delineation of lung cancer with FDG PET/CT during radiation therapy

@nl

type

Item

label

Delineation of lung cancer with FDG PET/CT during radiation therapy

@en

Delineation of lung cancer with FDG PET/CT during radiation therapy

@nl

prefLabel

Delineation of lung cancer with FDG PET/CT during radiation therapy

@en

Delineation of lung cancer with FDG PET/CT during radiation therapy

@nl

P1476

Delineation of lung cancer with FDG PET/CT during radiation therapy

@en

P2093

I Gardin

http://www.w3.org/2001/XMLSchema#string

J Ganem

http://www.w3.org/2001/XMLSchema#string

P Vera

http://www.w3.org/2001/XMLSchema#string

R Modzelewski

http://www.w3.org/2001/XMLSchema#string

S Hapdey

http://www.w3.org/2001/XMLSchema#string

S Thureau

http://www.w3.org/2001/XMLSchema#string

P2860

A contrast-oriented algorithm for FDG-PET-based delineation of tumour volumes for the radiotherapy of lung cancer: derivation from phantom measurements and validation in patient data.

A fuzzy locally adaptive Bayesian segmentation approach for volume determination in PET.

Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two facto

Impact of consensus contours from multiple PET segmentation methods on the accuracy of functional volume delineation.

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.

The role of PET/CT scanning in radiotherapy planning.

P2888

s13014-018-1163-2

P304

219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-018-1163-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1109822641

http://www.w3.org/2001/XMLSchema#string

P698

30419929

http://www.w3.org/2001/XMLSchema#string

P932

6233287

http://www.w3.org/2001/XMLSchema#string